AVITA Medical (RCEL) Revenue (2018 - 2025)

AVITA Medical's Revenue history runs 8 years deep, the most recent figure standing at $92.0 million for Q4 2025.

• Quarterly Revenue rose 409.75% year-over-year to $92.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $145.4 million (up 127.64% YoY) and the FY2025 annual result came in at $71.6 million, up 12.08% from the prior year.
• Revenue was $92.0 million for Q4 2025 at AVITA Medical, up from $16.9 million in the prior quarter.
• Across five years, Revenue topped out at $92.0 million in Q4 2025 and bottomed at $7.5 million in Q1 2022.
• A 5-year average of $18.9 million and a median of $14.7 million in 2023 frame the typical range for Revenue.
• Annual changes were most pronounced in 2021 — Revenue surged 415.59% — and 2022, when it plunged 65.15%.
• AVITA Medical's Revenue stood at $26.1 million in 2021, then plunged by 63.76% to $9.5 million in 2022, then jumped by 50.13% to $14.2 million in 2023, then rose by 27.14% to $18.0 million in 2024, then soared by 409.75% to $92.0 million in 2025.
• Business Quant data shows RCEL's Revenue at $92.0 million in Q4 2025, $16.9 million in Q3 2025, and $18.2 million in Q2 2025.